1 Department of Efficacy and Resistance to Anti-Tumor Targeted Therapies, University of Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.
2 Biomedical Innovation Deparment, Centro de Investigacion Cientifica y de Educacion Superior de Ensenada, Ensenada 22860, Mexico.
This Special Issue of Cancers covers different aspects of bone physiopathology in oncology that combine the microenvironment and the factors involved in bone metastasis dormancy and progression [...].